Singapore equities
About 30 SGX listcos show early interest in Value Unlock programme to lift valuations
Market participants say weak disclosure and poor investor engagement often drive mispricing on the exchange – gaps the initiative aims to close
Secondary listings on SGX set to grow in 2026, but regulatory frictions loom
Well-known companies with such listings here include DFI Retail Group, IHH Healthcare, Nio and Prudential
Catalist-listed MoneyMax proposes transfer to SGX mainboard
Move will enhance the long-term value for its shareholders
Strong January lifts odds of another record year for STI, further upside ahead: OCBC
It is often a ‘good period’ for investors to reposition their portfolios
‘One of the best years ever’: DBS’ equities head sees buoyant 2026 for Singapore IPOs
Art Karoonyavanich says the bank is involved with ‘quite a number’ of companies that could go public this year
Is S$5 billion enough? Panel weighs impact of EQDP on Singapore equity valuations
There is agreement that the sum has kickstarted things, and that the challenge would be to keep up the momentum built in 2025
Wealthy clients stocking up on Singapore equities to hedge against sliding greenback: BOS
The increase marks a sharp acceleration from the typical pace of growth in Singapore-focused allocations
US dollar slide sharpens case for Singapore stocks, says OCBC equities research head
Reits stand out as they offer good dividend yields with a cushion of at least 5 to 6%
Singapore market shrugs off Maduro ouster as world awaits resolution of Venezuelan crisis
Oil prices muted amid robust supply; Central American exporter has been an insignificant player after years of US sanctions and blockades
Beef up investor rights, but don’t tip the market towards litigation
Singapore’s push to enhance investor recourse is timely, but execution could open the floodgates to speculative claims and unintended pressure on listed companies
